US Map / Arizona
State AZ

Clinical Trials in Arizona

Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 242 actively recruiting studies with Arizona sites out of 242 registered in total. The busiest research areas in Arizona are Solid Tumor, Prostate Cancer, Obesity. Leading sponsors running trials in the state include Mayo Clinic, University of Arizona, AstraZeneca. By stage, Arizona trials break down as Phase 1 (37), Phase 2 (77), Phase 3 (80), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
242
Recruiting Now
242
← Back to US Map
Top Conditions in Arizona
Solid Tumor (6)Prostate Cancer (6)Obesity (6)Colorectal Cancer (4)Multiple Myeloma (3)Cancer (3)Advanced Solid Tumor (3)Developmental Language Disorder (3)Overweight (3)Colorectal Neoplasms (3)Carcinoma, Non-Small-Cell Lung (3)Graves' Disease (3)

Frequently Asked Questions — Clinical Trials in Arizona

How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 242 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 242. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Solid Tumor, Prostate Cancer, Obesity, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Arizona

NCT05677971 Phase 3
Recruiting
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People ...
Condition
Alpha1-Antitrypsin Deficiency
Enrollment
160 pts
Location
United States, Australia, Austria
Sponsor
Takeda
View Trial →
NCT05837663 N/A
Recruiting
Trifecta-Lung cfDNA-MMDx Study
Condition
Lung Transplantation
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
University of Alberta
View Trial →
NCT07571109 Phase 3
Recruiting
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps...
Condition
Obesity
Enrollment
300 pts
Location
United States, Australia, China
Sponsor
Novo Nordisk A/S
View Trial →
NCT07915609 Phase 3
Recruiting
A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoa...
Condition
Obesity
Enrollment
756 pts
Location
United States
Sponsor
Pfizer
View Trial →
NCT06736574 Phase 3
Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With S...
Condition
Heart Failure
Enrollment
1,800 pts
Location
United States, Canada, China
Sponsor
Cytokinetics
View Trial →
NCT07269210 Phase 2
Recruiting
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceride...
Condition
Severe Hypertriglyceridemia
Enrollment
60 pts
Location
United States, Canada, China
Sponsor
Eli Lilly and Company
View Trial →
NCT06619990 Phase 1, Phase 2
Recruiting
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Coliti...
Condition
Ulcerative Colitis (UC)
Enrollment
270 pts
Location
United States, Argentina, Australia
Sponsor
Xencor, Inc.
View Trial →
NCT05038150 Phase 1, Phase 2
Recruiting
Study of SGN1 in Patients With Advanced Solid Tumor
Condition
Advanced Solid Tumor
Enrollment
70 pts
Location
United States, China
Sponsor
Guangzhou Sinogen Pharmaceutic
View Trial →
NCT04372615 Phase 2
Recruiting
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
Condition
Autoimmune Encephalitis
Enrollment
116 pts
Location
United States, Netherlands, Spain
Sponsor
University of Utah
View Trial →
NCT07086976 Phase 3
Recruiting
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzab...
Condition
Autoimmune Haemolytic Anaemia
Enrollment
90 pts
Location
United States, Argentina, Austria
Sponsor
Sanofi
View Trial →
NCT05701917 N/A
Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombos...
Condition
Venous Thromboembolism
Enrollment
300 pts
Location
United States, Austria, Finland
Sponsor
Inari Medical
View Trial →
NCT05139017 Phase 2, Phase 3
Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care i...
Condition
DLBCL
Enrollment
290 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07641179 Phase 2
Recruiting
A Study to Evaluate MAR002 for Acromegaly
Condition
Acromegaly
Enrollment
72 pts
Location
United States
Sponsor
Marea Therapeutics
View Trial →
NCT06429735 N/A
Recruiting
Precise Robotically IMplanted Brain-Computer InterfacE
Condition
Tetraplegia/Tetraparesis
Enrollment
15 pts
Location
United States
Sponsor
Neuralink Corp
View Trial →
NCT07527910 Phase 2
Recruiting
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients W...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Enrollment
204 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT05222620 Phase 2
Recruiting
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIO...
Condition
Metastatic Malignant Neoplasm in the Brain
Enrollment
90 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT06312176 Phase 3
Recruiting
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combinatio...
Condition
Breast Neoplasms
Enrollment
1,200 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07683325 Phase 2
Recruiting
NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Com...
Condition
Fibrostenotic Crohn's Disease
Enrollment
320 pts
Location
United States, Serbia, United Kingdom
Sponsor
Agomab Spain S.L.U.
View Trial →
NCT06568549 Phase 4
Recruiting
Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRA...
Condition
Kidney Transplantation
Enrollment
350 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT07723963 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment ...
Condition
Juvenile Myoclonic Epilepsy
Enrollment
260 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
View Trial →
NCT06747117 N/A
Recruiting
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus ...
Condition
Lower Extremity Acute Limb Ischemia
Enrollment
300 pts
Location
United States, Australia, Brazil
Sponsor
Penumbra Inc.
View Trial →
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT04792489 Phase 2
Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
Condition
Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Enrollment
315 pts
Location
United States, Canada
Sponsor
Miltenyi Biomedicine GmbH
View Trial →
NCT03178149 Phase 1
Recruiting
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losin...
Condition
Age-Related Macular Degeneration
Enrollment
42 pts
Location
United States
Sponsor
Astellas Institute for Regener
View Trial →
NCT06425926 Phase 1, Phase 2
Recruiting
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Condition
Melanoma Stage IV
Enrollment
117 pts
Location
United States
Sponsor
Georgiamune Inc
View Trial →
Page 3 of 10 — 242 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology